GSK's two-drug HIV treatment meets main goal in late stage studies
GSK's two-drug HIV treatment meets main goal in late stage studies
- GlaxoSmithKline said on Thursday that its two-drug treatment for HIV, the virus that causes AIDS, met its main goal in late stage studies.
- GlaxoSmithKline said on Thursday that its two-drug treatment for HIV, the virus that causes AIDS, met its main goal in late stage studies.